United States · FDA National Drug Code directory
Cefdinir
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0904-7563_a0934baf-4745-4546-a63a-d4a660a188b3
- Product NDC
- 0904-7563
- Form
- CAPSULE
- Composition / generic term
- Cefdinir
- Labeler
- Major Pharmaceuticals
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20251027
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFDINIR — 300 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 3 BLISTER PACK in 1 CARTON (0904-7563-04) / 10 CAPSULE in 1 BLISTER PACK · 0904-7563-04
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →